Search results
2seventy bio, Inc. (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 hours ago2seventy bio, Inc. (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript May 8, 2024 2seventy bio, Inc....
Wedbush Comments on Gossamer Bio, Inc.’s Q2 2024 Earnings (NASDAQ:GOSS)
ETF DAILY NEWS· 11 hours agoGossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Wedbush lifted their Q2 2024 EPS estimates for Gossamer Bio in a research report issued on Monday, May ...
Bio-Techne Third Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 9 hours agoBio-Techne (NASDAQ:TECH) Third Quarter 2024 Results Key Financial Results Revenue: US$303.4m (up...
ProGro BIO Announces Successful Outcomes in Sustainable Farming Projects in Liberia
FOX 5 San Diego· 2 hours agoProGro BIO announced today that it is providing its 100% natural and organic microbial soil inoculant, Rhizol, and application knowledge to Sustainable Liberia, a US non-profit ...
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Zacks via Yahoo Finance· 1 day agoBio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased...
Bio-Rad Laboratories Maintains Full-Year Guide Despite Life Science Q1 Revenue Decline of 25 Percent
GenomeWeb News· 1 day agoThis story has been updated to include additional information about Bio-Rad's Droplet Digital PCR initiatives. NEW YORK – Executives at Bio-Rad Laboratories ...
Regenex Bio eyes FDA meeting to confirm pivotal DMD trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoRegenex Bio has announced it is meeting with the US Food and Drug Administration (FDA) with plans to...
Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook By Investing.com
Investing.com· 1 day agoIn the first quarter of 2024, Bio-Rad Laboratories, Inc. (NYSE: NYSE:BIO) reported a decrease in net...
2seventy bio Inc (TSVT) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and ...
GuruFocus.com via Yahoo Finance· 12 hours agoRelease Date: May 08, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points 2seventy bio Inc (NASDAQ:TSVT ...
Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ...
WFRV 5 Green Bay· 1 day agoBy rehabilitating donor organs deemed unfit for transplant, the xenogeneic cross-circulation platform holds potential to eliminate transplant waitlist mortality. NEW YORK, May 8, 2024 /PRNewswire ...